University of California, Irvine

UCI researchers launch first-of-its-kind coronavirus statistics portal

Site provides comparisons between Orange County, other jurisdictions

Newswise — Irvine, Calif., Aug. 10, 2020 — Scientists at the University of California, Irvine have unveiled a public website that provides up-to-date statistics on coronavirus infections in Orange County, with comparisons to neighboring and other California counties.

The site displays information collected from the California Open Data Portal in an easily comprehended format, giving visitors quick access to the most relevant data on hospitalized patients with COVID-19, intensive care unit patients, new daily cases and new daily deaths caused by the disease. It also offers color-coded Orange County maps, produced by UCI assistant professor of public health Daniel Parker, that show spatial patterns of growth in the number of cases, the number of tests and the fractions of positive tests from March through July.

Charts on the homepage reveal how the pandemic is affecting Alameda, Los Angeles, Orange, San Diego and Santa Clara counties. According to the developers, this is the first website to provide county-to-county comparisons of key coronavirus statistics.

“There is no shortage of COVID-19-related data visualizations out in the world, but what has been lacking is a platform for easy visualization and comparison of trends in California’s counties,” said Vladimir Minin, a UCI professor of statistics who led the team responsible for designing and creating the site. “Every county reports its coronavirus stats, but useful knowledge can be gained by holding up the numbers against other counties and normalizing by population size, which is what we have done.”

He said that hospitalization data in Orange County had become “alarming” in recent weeks and that the situation was even more explicitly dire when compared to other similar population centers in California.

“For example, Southern California residents may think that Los Angeles County is still an outlier in terms of being affected by the coronavirus spread, but the displayed trends clearly show that L.A. and Orange counties recently have become much closer to each other in some of the COVID-19 metrics,” Minin said.

In the future, the website team plans to add testing tallies, which are not available from all counties but are reported by L.A. and O.C. They also intend to increase the county comparisons.

Minin noted that the numbers backing up the charts, graphs and maps are based on seven-day moving averages, updated daily, and that the site’s images and code are shared under the most permissive public domain licenses to facilitate free use by entities outside UCI.

“What we’re doing is really simple from a technological standpoint,” said collaborator Padhraic Smyth, UCI Chancellor’s Professor of computer science, “but we felt that it was important to provide this type of data to individuals and the public in general to help inform their decision-making.”

The resource was developed under the guidance of an ad hoc COVID-19 awareness group at UCI that comprises members from the Department of Statistics, the Program in Public Health, the Center for Virus Research and the Infectious Disease Science Initiative. The group members’ research is supported by the National Science Foundation and the National Institutes of Health.

The website was built and is being maintained by Damon Bayer, Isaac Goldstein and Rachel Longjohn, Ph.D. students in the Donald Bren School of Information & Computer Sciences’ Department of Statistics.

About the University of California, Irvine: Founded in 1965, UCI is the youngest member of the prestigious Association of American Universities. The campus has produced three Nobel laureates and is known for its academic achievement, premier research, innovation and anteater mascot. Led by Chancellor Howard Gillman, UCI has more than 36,000 students and offers 222 degree programs. It’s located in one of the world’s safest and most economically vibrant communities and is Orange County’s second-largest employer, contributing $5 billion annually to the local economy. For more on UCI, visit www.uci.edu.

Media access: Radio programs/stations may, for a fee, use an on-campus ISDN line to interview UCI faculty and experts, subject to availability and university approval. For more UCI news, visit news.uci.edu. Additional resources for journalists may be found at communications.uci.edu/for-journalists.

 

NOTE TO EDITORS: GRAPHIC AVAILABLE AT
https://news.uci.edu/2020/08/10/uci-researchers-launch-first-of-its-kind-coronavirus-statistics-portal 




Filters close

Showing results

110 of 3321
Newswise: 243389_web.jpg
Released: 18-Sep-2020 10:55 AM EDT
Potential new drug to mitigate SARS-CoV-2 infection consequences
University of Malaga

Scientists from the Department of Cell Biology of the University of Malaga (UMA) and the Andalusian Centre for Nanomedicine and Biotechnology (BIONAND) have made progress in finding new rapid implementation therapies to combat the COVID-19 pandemic, identifying a new drug that could prevent or mitigate the consequences derived from SARS-CoV-2 infection.

Newswise: 243400_web.jpg
Released: 18-Sep-2020 10:40 AM EDT
Most homemade masks are doing a great job, even when we sneeze, study finds
University of Illinois at Urbana-Champaign

Studies indicate that homemade masks help combat the spread of viruses like COVID-19 when combined with frequent hand-washing and physical distancing.

access_time Embargo lifts in 2 days
Embargo will expire: 23-Sep-2020 8:00 AM EDT Released to reporters: 18-Sep-2020 10:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-Sep-2020 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 18-Sep-2020 8:30 AM EDT
Immunotherapy Drug Development Pipeline Continues Significant Growth in 2020 Despite Global Pandemic Impact
Cancer Research Institute

Despite the impact of the COVID-19 pandemic across the globe, there has been a resurgence of interest in immuno-oncology (I-O) preclinical and clinical development, bringing hope to cancer patients and physicians who treat them.

Released: 17-Sep-2020 5:50 PM EDT
AERA and OECD to Co-Host Webinar on Education Research Worldwide in a Covid and Post-Covid World
American Educational Research Association (AERA)

The American Educational Research Association (AERA) and the Organisation for Economic Co-operation and Development (OECD) will co-host a webinar on “Education Research Worldwide in a Covid and Post-Covid World” at 9:30-11:00 am EDT Wednesday, September 23.

Newswise: 243232_web.jpg
Released: 17-Sep-2020 4:20 PM EDT
Study shows first proof that a safer UV light effectively kills virus causing COVID-19
Hiroshima University

A study conducted by Hiroshima University researchers found that using Ultraviolet C light with a wavelength of 222 nanometers which is safer to use around humans effectively kills SARS-CoV-2 -- the first research in the world to prove its efficacy against the virus that causes COVID-19.

Newswise:Video Embedded american-academy-of-dermatology-honors-detroit-physician-iltefat-h-hamzavi-with-national-patient-care-hero-award
VIDEO
Released: 17-Sep-2020 4:00 PM EDT
American Academy of Dermatology honors Detroit physician Iltefat H. Hamzavi with national “Patient Care Hero” award
American Academy of Dermatology

The American Academy of Dermatology has named board-certified dermatologist Iltefat H. Hamzavi, MD, FAAD, a Patient Care Hero for his innovative use of light therapy to sanitize masks needed by frontline health care workers.

access_time Embargo lifts in 2 days
Embargo will expire: 22-Sep-2020 11:00 AM EDT Released to reporters: 17-Sep-2020 3:20 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 22-Sep-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 17-Sep-2020 3:05 PM EDT
New York State Department of Health Grants Emergency Use Authorization to Mount Sinai for Quantitative COVID-19 Antibody Test
Mount Sinai Health System

The Clinical Laboratories of The Mount Sinai Hospital has received emergency use authorization from the New York State Department of Health (NYSDOH) for quantitative use of Mount Sinai’s COVID-19 antibody test, making Mount Sinai’s lab the first in the country to run an authorized, fully quantitative antibody test that can deliver a precise numeric measurement of the level of antibodies in a patient’s blood


Showing results

110 of 3321

close
1.16769